COM:PLIANTRX
Pliant Therapeutics
- Stock
Last Close
12.73
21/11 21:00
Market Cap
669.01M
Beta: -
Volume Today
687.71K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | 0.50 - | ||||||
average payables | 1.91M - | 1.64M 14.45% | 2.50M 52.58% | 2.28M 8.87% | 3.06M 34.28% | ||
average receivables | 3.94M - | 8.37M 112.39% | 5.72M 31.67% | 2.07M 63.76% | 1.03M 50.18% | ||
book value per share | -0.05 - | -0.02 62.70% | 13.26 66,651.58% | 5.55 58.13% | 7.46 34.30% | 0.01 99.89% | |
capex per share | -0.14 - | -0.04 68.61% | -0.07 62.54% | -0.05 24.09% | -0.04 23.11% | -0.00 99.96% | |
capex to depreciation | -3.49 - | -0.87 75.17% | -1.17 35.02% | -1.27 8.79% | -0.97 24.12% | -0.50 48.18% | |
capex to operating cash flow | 0.08 - | 0.35 327.48% | 0.04 88.27% | 0.03 37.02% | 0.02 28.16% | 0.01 57.44% | |
capex to revenue | -0.02 - | -0.04 116.82% | -0.26 604.02% | -0.18 29.54% | -0.58 220.77% | ||
cash per share | 3.69 - | 4.71 27.53% | 12.97 175.55% | 5.60 56.86% | 7.88 40.86% | 0.01 99.89% | |
days of inventory on hand | |||||||
days payables outstanding | |||||||
days sales outstanding | 47.25 - | 81.72 72.96% | 100.31 22.76% | 77.86 22.38% | |||
debt to assets | 0.01 - | 0.00 52.74% | 0.00 74.32% | 0.03 3,295.98% | 0.05 38.70% | 0.02 50.77% | |
debt to equity | -0.60 - | -1.02 71.48% | 0.00 100.10% | 0.04 3,514.78% | 0.05 39.66% | 0.02 52.42% | |
dividend yield | |||||||
earnings yield | -0.09 - | 0.00 100.46% | -0.08 20,699.17% | -0.04 54.85% | -0.15 304.28% | -0.00 99.90% | |
enterprise value | 291.24M - | 379.61M 30.34% | 434.34M 14.42% | 439.46M 1.18% | 794.30M 80.75% | 1.06T 133,773.11% | |
enterprise value over ebitda | -9.63 - | -3.22K 33,312.93% | -10.43 99.68% | -21.99 110.82% | -6.48 70.52% | -5.77K 88,979.10% | |
ev to operating cash flow | -10.28 - | -138.04 1,242.67% | -11.65 91.56% | -5.83 50.02% | -8.39 44.10% | -9.14K 108,772.78% | |
ev to sales | 6.65 - | 10.39 56.10% | 58.04 458.76% | 82.01 41.31% | 673.01K 820,508.24% | ||
free cash flow per share | -1.86 - | -0.17 90.84% | -1.82 968.54% | -2.16 18.76% | -2.29 6.26% | -0.00 99.91% | |
free cash flow yield | -0.09 - | -0.01 90.84% | -0.08 901.76% | -0.16 99.88% | -0.12 25.79% | -0.00 99.91% | |
graham net net | -0.37 - | -0.51 39.00% | 12.72 2,581.62% | 5.02 60.52% | 7.03 40.04% | 0.01 99.89% | |
graham number | 1.48 - | 0.06 95.85% | 23.57 38,140.04% | 7.90 66.48% | 22.03 178.82% | 0.02 99.90% | |
income quality | 0.94 - | 4.36 365.79% | 0.90 79.41% | 0.78 13.56% | 0.77 1.07% | 0.72 6.01% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -73.48 - | -160.81 118.85% | -7.65 95.24% | ||||
interest debt per share | 0.03 - | 0.02 36.04% | 0.01 34.81% | 0.21 1,470.86% | 0.40 89.76% | 0.00 99.85% | |
inventory turnover | |||||||
invested capital | -0.60 - | -1.02 71.48% | 0.00 100.10% | 0.04 3,514.78% | 0.05 39.66% | 0.02 52.42% | |
market cap | 351.66M - | 464.97M 32.22% | 484.94M 4.29% | 483.93M 0.21% | 812.17M 67.83% | 1.06T 130,833.90% | |
net current asset value | -5.68M - | -7.60M 33.83% | 278.29M 3,762.18% | 187.28M 32.70% | 303.04M 61.81% | 466.92M 54.08% | |
net debt to ebitda | 2.00 - | 723.42 36,115.06% | 1.22 99.83% | 2.23 83.14% | 0.15 93.45% | 0.28 93.11% | |
net income per share | -1.83 - | 0.01 100.46% | -1.86 22,072.44% | -0.50 73.17% | -2.89 478.87% | -0.00 99.90% | |
operating cash flow per share | -1.72 - | -0.13 92.66% | -1.75 1,286.14% | -2.10 20.53% | -2.25 7.02% | -0.00 99.91% | |
payables turnover | |||||||
receivables turnover | 7.73 - | 4.47 42.18% | 3.64 18.54% | 4.69 28.83% | |||
research and ddevelopement to revenue | 0.83 - | 1.58 90.71% | 10.24 547.00% | 10.01 2.27% | 80.88 708.12% | ||
return on tangible assets | -0.46 - | 0.00 100.34% | -0.13 8,755.57% | -0.08 39.81% | -0.35 328.09% | -0.32 9.09% | |
revenue per share | 2.61 - | 1.96 25.04% | 0.21 89.22% | 0.23 9.12% | 0.00 99.99% | ||
roe | 34.33 - | -0.43 101.24% | -0.14 66.98% | -0.09 35.93% | -0.39 331.03% | -0.34 12.14% | |
roic | -187.90 - | 0.80 100.42% | -0.14 117.64% | -0.09 39.47% | -0.37 339.78% | -0.38 1.24% | |
sales general and administrative to revenue | 0.19 - | 0.41 115.56% | 3.64 781.30% | 4.12 13.34% | 36.66 788.84% | ||
shareholders equity per share | -0.05 - | -0.02 62.70% | 13.26 66,651.58% | 5.55 58.13% | 7.46 34.30% | 0.01 99.89% | |
stock based compensation to revenue | 0.03 - | 0.09 190.54% | 1.38 1,379.83% | 2.33 69.28% | 28.15 1,106.61% | ||
tangible asset value | -882K - | -435K 50.68% | 283.06M 65,171.49% | 199.06M 29.68% | 313.34M 57.41% | 473.58M 51.14% | |
tangible book value per share | -0.05 - | -0.02 62.70% | 13.26 66,651.58% | 5.55 58.13% | 7.46 34.30% | 0.01 99.89% | |
working capital | 56.65M - | 103.73M 83.11% | 279.15M 169.12% | 192.61M 31.00% | 316.40M 64.27% | 476.98M 50.75% |
All numbers in (except ratios and percentages)